NCT04898283 - Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses. | Biotech Hunter

Enrollment

180

Participants

Timeline

Start Date

May 31, 2021

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions

Rhinitis, AllergicRhinoconjunctivitisAsthma, Allergic

Interventions

BIOLOGICAL

10,000 MG01 +10,000 T521

Purified and polymerized with glutaraldehyde allergen extract, from a mixture of grasses (Phleum pratense, Holcus lanatus, Poa pratensis, Festuca pratensis, Lolium perenne and Dactylis glomerata) and cupressaceae (Juniperus oxycedrus), adsorbed on aluminum hydroxide. The other ingredients are: sodium chloride (0.9%), phenol (0.4%) and water for injections

BIOLOGICAL

30,000 MG01 +10,000 T521

Purified allergen extract polymerized with glutaraldehyde, from a mixture of grasses (Phleum pratense, Holcus lanatus, Poa pratensis, Festuca pratensis, Lolium perenne and Dactylis glomerata) and cupressaceae (Juniperus oxycedrus), adsorbed on aluminum hydroxide. The other ingredients are: sodium chloride (0.9%), phenol (0.4%) and water for injections.

OTHER

Placebo subcutaneous

The same solution and presentation as the active treatment, but without active ingredients

Trial Locations (27)

16400

RECRUITING

Cedt de Tarancón, Tarancón

24003

WITHDRAWN

Clinica privada, León

28003

RECRUITING

Hospital Cruz Roja Madrid, Madrid

28006

RECRUITING

Clínica Privada Dres Ojeda, Madrid

ACTIVE_NOT_RECRUITING

Clínica Subiza, Madrid

28029

WITHDRAWN

Hospital Carlos III (antiguo CAP José Marva), Madrid

28034

Hospital Universitario de Burgos, Burgos